protease inhibitors (Tanabe Seiyaku)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameprotease inhibitors (Tanabe Seiyaku)
Drug Alias NameTMC-95-BTMC-95-CTMC-95-ATMC-95-D
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTanabe Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTanabe Seiyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A